Company / Tangible Book Value per Share
Seres Therapeutics, Inc. Tangible Book Value per Share History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$1.59
FY2025
5-year range
-$0.68 / $1.90
FY2021-FY2025
Trend
+51.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Tangible Book Value per Share has fluctuated over the past 10 years, ranging from $-1.61 in FY2015 to $5.09 in FY2017.
Based on SEC 10-K filings.
1.59 in FY2025 with a 3-year CAGR of -5.7%.
Declined from $1.90 to $1.59 over the past 3 years.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -5.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, tangible book value per share increased 51.7% year-over-year.
- Peak tangible book value per share was recorded in FY2017.
- Lowest tangible book value per share in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.18 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.59 | +51.7% |
| FY2023 | $1.05 | -44.8% |
| FY2022 | $1.90 | +459.9% |
| FY2021 | -$0.53 | +22.9% |
| FY2020 | -$0.68 | -146.2% |
| FY2019 | $1.48 | -54.6% |
| FY2018 | $3.27 | -35.8% |
| FY2017 | $5.09 | +844.4% |
| FY2016 | -$0.68 | +57.6% |
| FY2015 | -$1.61 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 24, 2026